The Malaysian Reserve

Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in atopic ...

OTC Markets Hosts Virtual Investor Presentation with Quang Pham, Chairman and CEO of Cadrenal Therapeutics, and David Bautz, PhD, Senior Analyst at Zacks SCR

Hello, and welcome to the Life Science Investor Forum . On behalf of OTC Markets and our co-host, Zacks Small Cap Research , we are very pleased you have joined us. The next presentation of the day is ...

Nektar Therapeutics: Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in ...
Healio

Q&A: vMed conference is a venue to ‘get creative’ about the future of medicine

Sinai’s 8th Annual Virtual Medicine Conference, is taking place March 25-26 in Los Angeles. With a focus on the digital tools shaping the present and future of health care, the conference is a place ...